company-logo

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

ESSA Pharma Dividend Announcement

ESSA Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on ESSA Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

ESSA Pharma Dividend History

ESSA Pharma Dividend Yield

ESSA Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing ESSA Pharma stock? Use our calculator to estimate your expected dividend yield:

ESSA Pharma Financial Ratios

P/E ratio-2.89
PEG ratio0.05
P/B ratio0.62
ROE-20.17%
Payout ratio0.00%
Current ratio36.95
Quick ratio36.95
Cash Ratio24.05

ESSA Pharma Dividend FAQ

Does ESSA Pharma stock pay dividends?
ESSA Pharma does not currently pay dividends to its shareholders.
Has ESSA Pharma ever paid a dividend?
No, ESSA Pharma has no a history of paying dividends to its shareholders. ESSA Pharma is not known for its dividend payments.
Why doesn't ESSA Pharma pay dividends?
There are several potential reasons why ESSA Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will ESSA Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While ESSA Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is ESSA Pharma a dividend aristocrat?
ESSA Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is ESSA Pharma a dividend king?
ESSA Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is ESSA Pharma a dividend stock?
No, ESSA Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy ESSA Pharma stocks?
To buy ESSA Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy ESSA Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.